Bessemer Group Inc Capricor Therapeutics, Inc. Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 26 shares of CAPR stock, worth $335. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$335% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
136Shares Held
16.1MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$29.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$29 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$28.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.3 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $314M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...